Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
カンナビノイドの新用途
Document Type and Number:
Japanese Patent JP2011509989
Kind Code:
A
Abstract:
The present invention relates to the use of CBD alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in controlling cholesterol levels in a subject. It also relates to the use of THCV alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in increasing energy expenditure in a subject. Furthermore the CBD alone or in combination with another cannabinoid or the THCV alone or in combination with another cannabinoid are used as part of a regime to manage or treat type I or II diabetes, obesity, dyslipidaemia, related metabolic disorders and cardiovascular disease.

Inventors:
Jeffrey Guy
Stephen Wright
Michael Anthony Corthorn
Sao Earth O'Sullivan
Application Number:
JP2010542690A
Publication Date:
March 31, 2011
Filing Date:
January 21, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GW PHARMA LIMITED
International Classes:
A61K31/05; A23L1/30; A61K31/352; A61K36/18; A61P3/04; A61P3/06; A61P3/10; A61P9/00; C07D311/80
Foreign References:
WO2005077348A12005-08-25
WO2006054057A22006-05-26
WO2005120478A12005-12-22
Attorney, Agent or Firm:
Kyousei Tamura
Samejima Mutsumi
Masahiro Nitta
Kure Hidenori